Sunshine Biopharma Incorporated SBFM
NASDAQ · United States · Health Technology
$0.6880-0.09 (-11.00%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -1.15 | -1.20 | +4.2% | $9.30M | +6.9% | -5.0%$1.21→$1.15 |
| Q1 2026 | 2026-05-13 | -2.50 | — | — | — | — | -55.3%$10.50→$4.69 |
| Q4 2025 | 2026-04-03 | -4.60 | -2.70 | -70.4% | — | — | +11.5%$10.40→$11.60 |
| Q3 2025 | 2025-11-13 | -1.90 | — | — | — | — | -7.9%$17.70→$16.30 |
| Q2 2024 | 2024-08-16 | -1,988.00 | -6.00 | -33,033.3% | — | — | — |
| Q1 2024 | 2024-05-20 | -400.00 | -208.00 | -92.3% | — | — | — |
| Q4 2023 | 2024-03-28 | -1,140.00 | -600.00 | -90.0% | — | — | — |
| Q3 2023 | 2023-11-13 | -800.00 | -1,200.00 | +33.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.